User profiles for Giovanni B. Frisoni
Giovanni B FrisoniDirector, Centre de la mémoire Verified email at unige.ch Cited by 79092 |
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
In the past 8 years, both the International Working Group (IWG) and the US National Institute
on Aging–Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's …
on Aging–Alzheimer's Association have contributed criteria for the diagnosis of Alzheimer's …
Alzheimer's disease
Although the prevalence of dementia continues to increase worldwide, incidence in the
western world might have decreased as a result of better vascular care and improved brain …
western world might have decreased as a result of better vascular care and improved brain …
The clinical use of structural MRI in Alzheimer disease
Structural imaging based on magnetic resonance is an integral part of the clinical assessment
of patients with suspected Alzheimer dementia. Prospective data on the natural history of …
of patients with suspected Alzheimer dementia. Prospective data on the natural history of …
Distinct patterns of brain activity in young carriers of the APOE-ε4 allele
The APOE ε4 allele is a risk factor for late-life pathological changes that is also associated
with anatomical and functional brain changes in middle-aged and elderly healthy subjects. …
with anatomical and functional brain changes in middle-aged and elderly healthy subjects. …
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Alzheimer's disease (AD) is the leading cause of dementia, and because the primary risk
factor for AD is old age, the prevalence of the disease is increasing dramatically with ageing …
factor for AD is old age, the prevalence of the disease is increasing dramatically with ageing …
Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria
…, C Duyckaerts, S Epelbaum, GB Frisoni… - Alzheimer's & …, 2016 - Elsevier
During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD)
considering the disease as a continuum. Thanks to evolving biomarker research and …
considering the disease as a continuum. Thanks to evolving biomarker research and …
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
…, N Foskett, KS Frederiksen, Y Freund-Levi, GB Frisoni… - Jama, 2015 - jamanetwork.com
Importance Cerebral amyloid-β aggregation is an early pathological event in Alzheimer
disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid …
disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid …
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
In 2018, the US National Institute on Aging and the Alzheimer's Association proposed a
purely biological definition of Alzheimer's disease that relies on biomarkers. Although the …
purely biological definition of Alzheimer's disease that relies on biomarkers. Although the …
A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers
…, K Blennow, MC Carrillo, HH Feldman, GB Frisoni… - Neurology, 2016 - AAN Enterprises
Biomarkers have become an essential component of Alzheimer disease (AD) research and
because of the pervasiveness of AD pathology in the elderly, the same biomarkers are used …
because of the pervasiveness of AD pathology in the elderly, the same biomarkers are used …
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
The current conceptualization of Alzheimer disease (AD) is driven by the amyloid hypothesis,
in which a deterministic chain of events leads from amyloid deposition and then tau …
in which a deterministic chain of events leads from amyloid deposition and then tau …